Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Consultant Histopathologist, Southampton

Do you see an evolution of the Boston criteria with regards to IgG4 IHC given its presence in so many other inflammatory and malignant diseases?